{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04277637",
            "orgStudyIdInfo": {
                "id": "BGB-11417-101"
            },
            "organization": {
                "fullName": "BeiGene",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies",
            "officialTitle": "A Phase 1a/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 Inhibitor BGB-11417 in Patients With Mature B-Cell Malignancies",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-bcl-inhibitor-bgb-in-participants-with-mature-b-cell-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-03-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-02-18",
            "studyFirstSubmitQcDate": "2020-02-18",
            "studyFirstPostDateStruct": {
                "date": "2020-02-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "BeiGene",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine the safety, tolerability; and to define the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D); and to evaluate the safety and tolerability of the ramp-up dosing schedule and at the RP2D of BGB-11417 monotherapy, and when given in combination with zanubrutinib and obinutuzumab."
        },
        "conditionsModule": {
            "conditions": [
                "Mature B-Cell Malignancies"
            ],
            "keywords": [
                "NHL",
                "BCL2 Inhibitor",
                "CLL",
                "MCL",
                "MZL",
                "SLL",
                "WM"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 537,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "BGB-11417 Monotherapy Dose Finding: Part 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) including follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) or transformed NHL, mantle cell lymphoma (MCL); Waldenstr\u00f6ms macroglobulinemia (WM); and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) will receive oral BGB-11417 until the maximum tolerated dose (MTD) (or maximum ascending dose (MAD)) and recommended phase 2 dose can be determined",
                    "interventionNames": [
                        "Drug: BGB-11417"
                    ]
                },
                {
                    "label": "BGB-11417 Monotherapy Expansion Cohorts: Part 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with R/R indolent NHL including FL, MZL; aggressive NHL including DLBCL, transformed NHL; CLL/SLL with low tumor burden or low creatine clearance; CLL/SLL with without high tumor burden or low creatine clearance will receive oral BGB-11417 at the RP2D dose to further define the safety profile",
                    "interventionNames": [
                        "Drug: BGB-11417"
                    ]
                },
                {
                    "label": "BGB-11417 + Zanubrutinib Combination Therapy Dose Finding: Part 3",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with R/R indolent NHL including FL, MZL; aggressive NHL including DLBCL, transformed NHL; R/R MCL; R/R or treatment-na\u00efve (TN) CLL/SLL will receive oral BGB-11417 until RP2D can be determined in combination with zanubrutinib",
                    "interventionNames": [
                        "Drug: BGB-11417",
                        "Drug: Zanubrutinib"
                    ]
                },
                {
                    "label": "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 4",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with R/R indolent NHL including FL, MZL; aggressive NHL including DLBCL, transformed NHL; R/R MCL; R/R or treatment-na\u00efve (TN) CLL/SLL will receive oral BGB-11417 at an RP2D dose to further define the safety profile in combination with zanubrutinib",
                    "interventionNames": [
                        "Drug: BGB-11417",
                        "Drug: Zanubrutinib"
                    ]
                },
                {
                    "label": ": BGB-11417 + Zanubrutinib Combination Therapy Dose Escalation: Part 5",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with treatment na\u00efve CLL/SLL will receive oral BGB-11417 until RP2D can be determined in combination with obinutuzumab without and with zanubrutinib.",
                    "interventionNames": [
                        "Drug: BGB-11417",
                        "Drug: Zanubrutinib"
                    ]
                },
                {
                    "label": "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 6",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with treatment na\u00efve CLL/SLL will receive oral BGB-11417 at an RP2D dose to further define the safety profile in combination with obinutuzumab without and with zanubrutinib",
                    "interventionNames": [
                        "Drug: BGB-11417",
                        "Drug: Zanubrutinib",
                        "Drug: obinutuzumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "BGB-11417",
                    "description": "Film-coated tablets administered once daily at a dose as specified in the treatment arm",
                    "armGroupLabels": [
                        ": BGB-11417 + Zanubrutinib Combination Therapy Dose Escalation: Part 5",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 4",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 6",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Finding: Part 3",
                        "BGB-11417 Monotherapy Dose Finding: Part 1",
                        "BGB-11417 Monotherapy Expansion Cohorts: Part 2"
                    ],
                    "otherNames": [
                        "Sonrotoclax"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Zanubrutinib",
                    "description": "320 mg daily administered as two 80-mg capsules twice a day (160 mg twice a day) or as four 80-mg capsules once a day (320 mg once a day)",
                    "armGroupLabels": [
                        ": BGB-11417 + Zanubrutinib Combination Therapy Dose Escalation: Part 5",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 4",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 6",
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Finding: Part 3"
                    ],
                    "otherNames": [
                        "BGB-3111"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "obinutuzumab",
                    "description": "Given as an intravenous infusion administered per label.",
                    "armGroupLabels": [
                        "BGB-11417 + Zanubrutinib Combination Therapy Dose Expansion: Part 6"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants Experiencing Treatment Emergent Adverse Events (TEAEs)",
                    "timeFrame": "Up to 30 days after the last dose of study drug, an average of 18 months"
                },
                {
                    "measure": "Number of Participants Experiencing Serious Adverse Events (SAEs)",
                    "timeFrame": "Up to 30 days after the last dose of study drug, an average of 18 months"
                },
                {
                    "measure": "Number of Participants Experiencing Adverse Events (AEs) leading to discontinuation of BGB-11417",
                    "timeFrame": "Up to 30 days after the last dose of study drug, an average of 18 months"
                },
                {
                    "measure": "Part 1, Part 3: Maximum Tolerated Dose (MTD)",
                    "timeFrame": "Day 1 to 21 days target dose of the study drug, an average of 18 months"
                },
                {
                    "measure": "Part 1, Part 3: Maximum RP2D of BGB-11417",
                    "timeFrame": "Day 1 to last dose of study drug, an average of 18 months"
                },
                {
                    "measure": "Part 1, Part 3: Number of participants experiencing tumor lysis syndrome (TLS) relevant events",
                    "timeFrame": "Up to 30 days after the last dose of study drug, an average of 18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Maximum Observed Plasma Concentration (Cmax) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Area Under the Concentration-Time Curve from Time 0 to the Last Quantifiable Concentration (AUC0-last) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-\u221e) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Time Taken for Half the Initial Dose Administered to Be Eliminated from The Body (T1/2) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Time to Maximum Plasma Concentration (Tmax) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Apparent Clearance (CL/F) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Apparent volume of distribution (Vz/F) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Steady State Area Under the Concentration-Time Curve of 0 - Last Day (AUCLast, ss) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 3, Part 4: Steady State Area Under the Concentration-Time Curve of 0 - Last Day (AUCLast, ss) of zanubrutinib",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Steady State Maximum Observed Plasma Concentration (Cmax, ss) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 3, Part 4: Steady State Maximum Observed Plasma Concentration (Cmax, ss) of zanubrutinib",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Steady State Trough Observed Plasma Concentration (Ctrough, SS) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 3, Part 4: Steady State Trough Observed Plasma Concentration (Ctrough, SS) of zanubrutinib",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Steady State Time to Maximum Plasma Concentration (Tmax, ss) of BGB-11417",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 3, Part 4: Steady State Time to Maximum Plasma Concentration (Tmax, ss) of zanubrutinib",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 2: AUC of BGB-11417 administered after a high fat/calorie meal (HF-Fed)",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 2: Cmax of BGB-11417 administered after a high fat/calorie meal (HF-Fed)",
                    "timeFrame": "Predose up to 12 hours postdose"
                },
                {
                    "measure": "Part 2, Part 4, Part 6: Overall Response Rate (ORR) as Assessed by the Investigator",
                    "description": "ORR is defined as the proportion of participants who had confirmed complete response Complete Response (CR) or Partial Response (PR)",
                    "timeFrame": "Up to 30 days after the last dose of study drug, an average of 18 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Confirmed diagnosis of one of the following:\n\nNHL Cohorts:\n\n1. MZL i. R/R extranodal, splenic, or nodal MZL defined as disease that relapsed after, or was refractory to, at least one prior therapy ii. Active disease requiring treatment\n2. FL i. R/R FL (Grade 1, 2 or 3a based on the WHO 2008 classification of tumors of hematopoietic and lymphoid tissue) and defined as disease that relapsed after, or was refractory to, at least 1 prior systemic therapy\n3. DLBCL i. R/R DLBCL (including all subtypes of DLBCL) defined as disease that relapsed after, or was refractory to, at least two prior systemic therapies and has either progressed following or is not a candidate for autologous stem cell transplant (due to comorbidities or non-responsiveness to salvage chemotherapy)\n4. Transformed indolent B-cell NHL i. Any lymphoma otherwise eligible for Part 1 that has transformed into a more aggressive lymphoma. Patients with transformation from CLL or SLL (Richter's transformation) are not eligible for Part 1\n\n   CLL/SLL Cohorts:\n5. CLL/SLL diagnosis that meets the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria i. Disease characterized as Treatment Naive (TN) or R/R disease defined as disease that relapsed after, or was refractory to, at least 1 prior therapy ii. Requiring treatment as defined by history\n\n   MCL cohorts:\n6. WHO-defined MCL I. R/R MCL defined as disease that relapsed after, or was refractory to, at least 1 prior systemic therapy; ii. Requiring treatment in the opinion of the investigatorr\n\nWM cohorts:\n\ng. WHO-defined WM (clinical and definitive histologic diagnosis) i. R/R disease defined as disease that relapsed after, or was refractory to, at least 1 prior therapy; ii. Meeting at least 1 criterion for treatment according to consensus panel criteria from the Seventh International Workshop on Waldenstr\u00f6m's Macroglobulinemia (Dimopoulos et al 2014)\n\n* Measurable disease by computed tomography (CT)/magnetic resonance imaging (MRI), defined as:\n\n  1. CLL: at least 1 lymph node \\> 1.5 cm in longest diameter and measurable in 2 perpendicular dimensions or clonal lymphocytes measured by flow cytometry\n  2. DLBCL, FL, MZL, SLL: at least 1 lymph node \\> 1.5 cm in longest diameter OR 1 extranodal lesion \\> 1.0 cm in the longest diameter, measurable in at least 2 perpendicular dimensions. For MZL, isolated splenomegaly is considered measurable for this study\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2\n* Adequate organ function\n* Adequate pancreatic function indicated by:\n\n  1. Serum amylase \u2264 1.5 x upper limit of normal (ULN)\n  2. Serum lipase \u2264 1.5 x ULN\n\nKey Exclusion Criteria:\n\n* Known central nervous system involvement by lymphoma/leukemia\n* Known plasma cell neoplasm, prolymphocytic leukemia, history of or currently suspected Richter's syndrome\n* Prior therapy \u2265 2 months with or progression on a B-cell lymphoma-2 (Bcl-2) inhibitor\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BeiGene",
                    "role": "CONTACT",
                    "phone": "1-877-828-5568",
                    "email": "clinicaltrials@beigene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Simpson",
                    "affiliation": "BeiGene",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "UCLA Hematologyoncology",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Kansas Medical Center Research Institute",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Mayo Clinic Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "John Theurer Cancer Center Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Columbia University Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center Mskcc",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "The James Cancer Hospital and Solove Research Institute At Ohio State University",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Upmc Hillman Cancer Center(Univ of Pittsburgh)",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "Md Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Research Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Concord Repatriation General Hospital",
                    "status": "RECRUITING",
                    "city": "Concord",
                    "state": "New South Wales",
                    "zip": "2139",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.84722,
                        "lon": 151.10381
                    }
                },
                {
                    "facility": "Orange Health Service (Central West Cancer Care Centre)",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "New South Wales",
                    "zip": "2800",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.28397,
                        "lon": 149.10018
                    }
                },
                {
                    "facility": "Pindara Private Hospital",
                    "status": "RECRUITING",
                    "city": "Benowa",
                    "state": "Queensland",
                    "zip": "4217",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -28.01667,
                        "lon": 153.4
                    }
                },
                {
                    "facility": "John Flynn Private Hospital",
                    "status": "RECRUITING",
                    "city": "Tugun",
                    "state": "Queensland",
                    "zip": "4224",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -28.15,
                        "lon": 153.5
                    }
                },
                {
                    "facility": "Royal Adelaide Hospital",
                    "status": "RECRUITING",
                    "city": "Adelaide",
                    "state": "South Australia",
                    "zip": "5000",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -34.92866,
                        "lon": 138.59863
                    }
                },
                {
                    "facility": "Flinders Medical Centre",
                    "status": "RECRUITING",
                    "city": "Bedford PK",
                    "state": "South Australia",
                    "zip": "5042",
                    "country": "Australia"
                },
                {
                    "facility": "Box Hill Hospital",
                    "status": "RECRUITING",
                    "city": "Box Hill",
                    "state": "Victoria",
                    "zip": "3128",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.81887,
                        "lon": 145.12545
                    }
                },
                {
                    "facility": "Monash Health",
                    "status": "RECRUITING",
                    "city": "Clayton",
                    "state": "Victoria",
                    "zip": "3168",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.91667,
                        "lon": 145.11667
                    }
                },
                {
                    "facility": "St Vincents Hospital Melbourne",
                    "status": "RECRUITING",
                    "city": "Fitzroy",
                    "state": "Victoria",
                    "zip": "3065",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.79839,
                        "lon": 144.97833
                    }
                },
                {
                    "facility": "Peter Maccallum Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3000",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "The Alfred Hospital",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3004",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Linear Clinical Research",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden",
                    "status": "RECRUITING",
                    "city": "Dresden",
                    "zip": "01307",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.05089,
                        "lon": 13.73832
                    }
                },
                {
                    "facility": "Universitaetsklinikum Ulm, Innere Medizin Iii",
                    "status": "RECRUITING",
                    "city": "Ulm",
                    "zip": "89081",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.39841,
                        "lon": 9.99155
                    }
                },
                {
                    "facility": "Ospedale San Raffaele",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20132",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20162",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Ospedale Santa Maria Della Misericordia",
                    "status": "RECRUITING",
                    "city": "Perugia",
                    "zip": "6132",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.1122,
                        "lon": 12.38878
                    }
                },
                {
                    "facility": "Azienda Unita Sanitaria Locale Di Ravenna",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "zip": "48121",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "Fondazione Policlinico Universitario Agostino Gemelli",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "168",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Centroricerche Cliniche Di Verona Srl",
                    "status": "RECRUITING",
                    "city": "Verona",
                    "zip": "37134",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.4299,
                        "lon": 10.98444
                    }
                },
                {
                    "facility": "Auckland City Hospital",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "North Shore Hospital",
                    "status": "RECRUITING",
                    "city": "Takapuna",
                    "zip": "0622",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.79167,
                        "lon": 174.77583
                    }
                },
                {
                    "facility": "Wellington Regional Hospital (Ccdhb)",
                    "status": "RECRUITING",
                    "city": "Wellington",
                    "zip": "6021",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -41.28664,
                        "lon": 174.77557
                    }
                },
                {
                    "facility": "Hospital de La Santa Creu I Sant Pau",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08025",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Vall D Hebron Institute of Oncology Vhio",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Ico H Duran I Reynals",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08907",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "8036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Start Madrid Fundacion Jimenez Diaz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Clinica Universidad de Navarra Pamplona",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "zip": "31008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Hospital Universitario de Salamanca",
                    "status": "RECRUITING",
                    "city": "Salamanca",
                    "zip": "37007",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.96882,
                        "lon": -5.66388
                    }
                },
                {
                    "facility": "Hospital Universitario Marques de Valdecilla",
                    "status": "RECRUITING",
                    "city": "Santander",
                    "zip": "39008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.46472,
                        "lon": -3.80444
                    }
                },
                {
                    "facility": "The Leeds Teaching Hospitals Nhs Trust",
                    "status": "RECRUITING",
                    "city": "Leeds",
                    "zip": "LS9 7TF",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                },
                {
                    "facility": "Oxford University Hospitals Nhs Foundation Trust",
                    "status": "RECRUITING",
                    "city": "Oxford",
                    "zip": "OX42PG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.75222,
                        "lon": -1.25596
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000543332",
                    "term": "Obinutuzumab"
                },
                {
                    "id": "C000629551",
                    "term": "Zanubrutinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M42199",
                    "name": "Zanubrutinib",
                    "asFound": "Flavor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M288906",
                    "name": "Obinutuzumab",
                    "asFound": "Plate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T385",
                    "name": "Creatine",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}